⌘K

Home/Filings/4/0001062993-23-007574

4//SEC Filing

Borges Luis 4

Accession 0001062993-23-007574

CIK 0001850119other

View on SEC.gov Company Profile

Filed

Mar 22, 8:00 PM ET

Accepted

Mar 23, 7:31 PM ET

Size

18.2 KB

Accession

0001062993-23-007574

Insider Transaction Report

Form 4

Period: 2023-03-21

Century Therapeutics, Inc.IPSC

Chief Scientific Officer

Transactions

Exercise/Conversion
Common Stock
2023-03-21$1.03/sh+63,616$65,524→ 107,366 total
Sale
Common Stock
2023-03-21$3.77/sh−63,616$239,870→ 43,750 total
Exercise/Conversion
Common Stock
2023-03-22$1.03/sh+65,698$67,669→ 109,448 total
Sale
Common Stock
2023-03-22$3.72/sh−65,698$244,640→ 43,750 total
Exercise/Conversion
Common Stock
2023-03-23$1.03/sh+220,930$227,558→ 264,680 total
Sale
Common Stock
2023-03-23$3.55/sh−15,597$55,369→ 249,083 total
Exercise/Conversion
Stock Option (right to buy)
2023-03-21−63,616→ 294,080 total
Exercise: $1.03Exp: 2029-07-17→ Common Stock (63,616 underlying)
Exercise/Conversion
Stock Option (right to buy)
2023-03-22−65,698→ 228,382 total
Exercise: $1.03Exp: 2029-07-17→ Common Stock (65,698 underlying)
Exercise/Conversion
Stock Option (right to buy)
2023-03-23−220,930→ 7,452 total
Exercise: $1.03Exp: 2029-07-17→ Common Stock (220,930 underlying)

Footnotes (3)

[F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.75 to $3.935, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.57 to $3.79, inclusive.
[F3]The option vests 25% on April 1, 2020, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Century Therapeutics, Inc.

CIK 0001850119

Entity typeother

Related Parties

1

filerCIK 0001684015

Filing Metadata

Form type: 4
Filed: Mar 22, 8:00 PM ET
Accepted: Mar 23, 7:31 PM ET
Size: 18.2 KB

View on SEC.gov